Makoto Yamasaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Makoto Yamasaki has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
- Kiyokazu Nakajima
Department of Next Generation Endoscopic Intervention (Project ENGINE) The University of Osaka Graduate School of Medicine Osaka Japan
4 shared publications Takashi Harino
Department of Upper Gastrointestinal Surgery, Kansai Medical University, Hirakata, Japan
4 shared publications- Tomoki Makino
Department of Gastroenterological Surgery, The University of Osaka Graduate School of Medicine, Suita, Japan
4 shared publications - Tsuyoshi Takahashi
Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan
4 shared publications - Yukinori Kurokawa
Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine , Osaka
4 shared publications - Hidetoshi Eguchi
Department of Gastroenterological Surgery The University of Osaka Graduate School of Medicine Suita Japan
3 shared publications
Latest Publications
- 2 September 2026
- Published by Springer Nature
- p. 279-284
Gastrointestinal Stromal Tumor in the Stomach
- 1 August 2026
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 31 (10) , 2492-2501
Return to work after upper gastrointestinal cancer surgery: questionnaire-based observational study
- 1 August 2026
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 31 (10) , 2492-2501
Return to work after upper gastrointestinal cancer surgery: questionnaire-based observational study
- 2 June 2026
- Published by Springer Nature in Esophagus
Surgical technique for partial-layer tracheal resection for esophageal cancer with tracheal invasion
Combined resection for tracheal invasion in esophageal cancer is extremely challenging. Tracheal resection with cervical or mediastinal tracheostomy is often performed; however, this procedure has high morbidity rates and results in loss of voice. We present our experience performing a partial-layer tracheal resection, "tracheal shaving," for esophageal cancer with tracheal invasion. We successfully performed tracheal adventitia and tracheal muscle resection in a patient with adventitial invasion, and the shaving area was reinforced by omental covering along with a gastric tube reconstructed through the posterior mediastinum. We believe that our "tracheal shaving" technique may potentially allow curative resection in selected T4 cases while preserving laryngeal function. It may serve as a minimally invasive alternative to conventional tracheal resection, although further evaluation is required.
- 2 June 2026
- Published by Springer Nature in Esophagus
Surgical technique for partial-layer tracheal resection for esophageal cancer with tracheal invasion
Combined resection for tracheal invasion in esophageal cancer is extremely challenging. Tracheal resection with cervical or mediastinal tracheostomy is often performed; however, this procedure has high morbidity rates and results in loss of voice. We present our experience performing a partial-layer tracheal resection, "tracheal shaving," for esophageal cancer with tracheal invasion. We successfully performed tracheal adventitia and tracheal muscle resection in a patient with adventitial invasion, and the shaving area was reinforced by omental covering along with a gastric tube reconstructed through the posterior mediastinum. We believe that our "tracheal shaving" technique may potentially allow curative resection in selected T4 cases while preserving laryngeal function. It may serve as a minimally invasive alternative to conventional tracheal resection, although further evaluation is required.
- 22 August 2024
- Published by Springer Nature in Esophagus
- Vol. 21 (4) , 472-483
The impact of time to postoperative recurrence on the prognosis of patients with esophageal cancer post recurrence: exploratory analysis of OGSG 1003
Background The association between recurrence timing and prognosis in patients with locally advanced resectable esophageal cancer undergoing neoadjuvant chemotherapy (NAC) followed by esophagectomy remains unclear. This study aimed to clarify this association using multicenter prospective clinical trial data. Methods Among 162 patients enrolled in a NAC phase II study comparing the efficacy of cisplatin and fluorouracil plus docetaxel with cisplatin and fluorouracil plus adriamycin, 64 patients with recurrence after R0 resection were included in this study. We evaluated the association between recurrence timing and overall survival after recurrence (OSr), along with clinicopathological factors associated with recurrence timing and OSr. Results Among 64 patients, 46 (71.9%) and 59 (92.2%) experienced recurrence within 1 and 2 years after surgery, respectively. Groups based on recurrence timing, including ≤ 6, 6–12, and > 12 months, had median OSr of 3.6, 13.9, and 13.4 months, respectively. The prognosis was significantly poorer for patients with recurrence ≤ 6 months after surgery than for other patients (P < 0.001). Multivariate analysis revealed pathological lymph node staging as an independent factor associated with early recurrence (odds ratio: 3.46, 95% confidence interval: 1.47–8.02, P = 0.0045). On the other hand, multivariate analysis for factors associated with OSr revealed pT (hazard ratio [HR]: 1.91, 95%CI 1.26–2.88, P = 0.0022), early recurrence (HR: 6.88, 95%CI 2.68–17.6, P < 0.001), and treatment after recurrence, with both local treatment (HR: 0.47, 95%CI 0.22–0.98, P = 0.043) and chemotherapy (HR: 0.25, 95%CI 0.11–0.58, P = 0.0011) as independent prognostic factors. Conclusion Patients with advanced esophageal cancer experiencing recurrence within 6 months after esophagectomy following NAC have an extremely poor prognosis, suggesting that an advanced pN stage is associated with early recurrence.
- 22 August 2024
- Published by Springer Nature in Esophagus
- Vol. 21 (4) , 472-483
The impact of time to postoperative recurrence on the prognosis of patients with esophageal cancer post recurrence: exploratory analysis of OGSG 1003
Background The association between recurrence timing and prognosis in patients with locally advanced resectable esophageal cancer undergoing neoadjuvant chemotherapy (NAC) followed by esophagectomy remains unclear. This study aimed to clarify this association using multicenter prospective clinical trial data. Methods Among 162 patients enrolled in a NAC phase II study comparing the efficacy of cisplatin and fluorouracil plus docetaxel with cisplatin and fluorouracil plus adriamycin, 64 patients with recurrence after R0 resection were included in this study. We evaluated the association between recurrence timing and overall survival after recurrence (OSr), along with clinicopathological factors associated with recurrence timing and OSr. Results Among 64 patients, 46 (71.9%) and 59 (92.2%) experienced recurrence within 1 and 2 years after surgery, respectively. Groups based on recurrence timing, including ≤ 6, 6–12, and > 12 months, had median OSr of 3.6, 13.9, and 13.4 months, respectively. The prognosis was significantly poorer for patients with recurrence ≤ 6 months after surgery than for other patients (P < 0.001). Multivariate analysis revealed pathological lymph node staging as an independent factor associated with early recurrence (odds ratio: 3.46, 95% confidence interval: 1.47–8.02, P = 0.0045). On the other hand, multivariate analysis for factors associated with OSr revealed pT (hazard ratio [HR]: 1.91, 95%CI 1.26–2.88, P = 0.0022), early recurrence (HR: 6.88, 95%CI 2.68–17.6, P < 0.001), and treatment after recurrence, with both local treatment (HR: 0.47, 95%CI 0.22–0.98, P = 0.043) and chemotherapy (HR: 0.25, 95%CI 0.11–0.58, P = 0.0011) as independent prognostic factors. Conclusion Patients with advanced esophageal cancer experiencing recurrence within 6 months after esophagectomy following NAC have an extremely poor prognosis, suggesting that an advanced pN stage is associated with early recurrence.
- Open Access
- 23 October 2023
- Published by Springer Nature in Surgical Case Reports
- Vol. 9 (1) , 1-7
Surgery for multiple gastric gastrointestinal stromal tumors and large esophageal diverticulum related to germline mutation of the KIT gene: a case report
Background: Familial gastrointestinal stromal tumors (GISTs) are mesenchymal tumors of the digestive tract caused by germline gain-of-function mutations in the KIT gene or platelet-derived growth factor receptor alpha gene (PDGFRA). These mutations cause not only multiple GISTs but also diffuse hyperplasia of interstitial cells of Cajal (ICCs), which is related to esophageal motility disorder. Case presentation: A 53-year-old man was referred to our hospital because of anemia and dysphagia. Fifteen years earlier, he had undergone a laparoscopic partial gastrectomy for multiple gastric GISTs with a germline mutation in exon 17 of the KIT gene. An upper gastrointestinal endoscopy revealed that the patient had multiple gastric GISTs and a large esophageal diverticulum directly above the esophagogastric junction. The largest gastric tumor was 7 cm, with a delle that might cause bleeding. Because the patient presented with dysphagia, we performed video-assisted thoracic esophagectomy and laparoscopic-assisted proximal gastrectomy simultaneously. The patient had survived without metastasis for 4 years after surgery and dysphagia had improved. Conclusions: This is the first report of successful laparoscopic–thoracoscopic surgery for a patient with familial gastric GISTs accompanied with a large esophageal diverticulum.
- 23 October 2023
- Published by Springer Nature in Surgical Case Reports
- Vol. 9 (1) , 1-7
Open AccessSurgery for multiple gastric gastrointestinal stromal tumors and large esophageal diverticulum related to germline mutation of the KIT gene: a case report
Background: Familial gastrointestinal stromal tumors (GISTs) are mesenchymal tumors of the digestive tract caused by germline gain-of-function mutations in the KIT gene or platelet-derived growth factor receptor alpha gene (PDGFRA). These mutations cause not only multiple GISTs but also diffuse hyperplasia of interstitial cells of Cajal (ICCs), which is related to esophageal motility disorder. Case presentation: A 53-year-old man was referred to our hospital because of anemia and dysphagia. Fifteen years earlier, he had undergone a laparoscopic partial gastrectomy for multiple gastric GISTs with a germline mutation in exon 17 of the KIT gene. An upper gastrointestinal endoscopy revealed that the patient had multiple gastric GISTs and a large esophageal diverticulum directly above the esophagogastric junction. The largest gastric tumor was 7 cm, with a delle that might cause bleeding. Because the patient presented with dysphagia, we performed video-assisted thoracic esophagectomy and laparoscopic-assisted proximal gastrectomy simultaneously. The patient had survived without metastasis for 4 years after surgery and dysphagia had improved. Conclusions: This is the first report of successful laparoscopic–thoracoscopic surgery for a patient with familial gastric GISTs accompanied with a large esophageal diverticulum.
- 26 May 2023
- Published by Springer Nature in Esophagus
- Vol. 20 (4) , 740-748
Impact of MRI on the post-therapeutic diagnosis of T4 esophageal cancer
Background Opportunities for T4b esophageal cancer patients to receive curative surgery are increasing with the development of multidisciplinary treatments. However, the best modality to accurately diagnose infiltration to the organs surrounding T4b esophageal cancer is still unknown. The aim of this study was to determine the performance of CT and MRI in diagnosing T stage in T4b esophageal cancer, with reference to the pathological diagnosis. Methods A retrospective medical records review of patients with T4b esophageal cancer patients from January 2017 to December 2021 was conducted. Among 125 patients who were treated for cT4b esophageal cancer in Osaka University Hospital, 30 patients were diagnosed with cT4b esophageal cancer by CT, ycT staging with CT (contrast-enhanced images) and MRI (T2-FSE images), and curative R0 resection was performed. Preoperative MRI staging was independently performed by two experienced radiologists. The diagnostic performance of CT and MRI were examined using McNemar’s test. Results Nineteen and 12 patients were diagnosed with ycT4b by CT and MRI, respectively. Combined T4b organ resection was performed in 15 patients. A pathological diagnosis of ypT4b was made in 11 cases. In comparison to CT, MRI showed a higher diagnostic performance, specificity (47% vs. 89%, p = 0.013), and accuracy (60% vs. 90%, p = 0.015) for CT vs. MRI. Conclusions Our results—with reference to the pathological diagnosis—revealed that MRI had a superior diagnostic performance to CT for diagnosing T4b esophageal cancer invading the surrounding organs. An accurate diagnosis of T4b esophageal cancer may facilitate the implementation of appropriate treatment strategies.
- 26 May 2023
- Published by Springer Nature in Esophagus
- Vol. 20 (4) , 740-748
Impact of MRI on the post-therapeutic diagnosis of T4 esophageal cancer
Background Opportunities for T4b esophageal cancer patients to receive curative surgery are increasing with the development of multidisciplinary treatments. However, the best modality to accurately diagnose infiltration to the organs surrounding T4b esophageal cancer is still unknown. The aim of this study was to determine the performance of CT and MRI in diagnosing T stage in T4b esophageal cancer, with reference to the pathological diagnosis. Methods A retrospective medical records review of patients with T4b esophageal cancer patients from January 2017 to December 2021 was conducted. Among 125 patients who were treated for cT4b esophageal cancer in Osaka University Hospital, 30 patients were diagnosed with cT4b esophageal cancer by CT, ycT staging with CT (contrast-enhanced images) and MRI (T2-FSE images), and curative R0 resection was performed. Preoperative MRI staging was independently performed by two experienced radiologists. The diagnostic performance of CT and MRI were examined using McNemar’s test. Results Nineteen and 12 patients were diagnosed with ycT4b by CT and MRI, respectively. Combined T4b organ resection was performed in 15 patients. A pathological diagnosis of ypT4b was made in 11 cases. In comparison to CT, MRI showed a higher diagnostic performance, specificity (47% vs. 89%, p = 0.013), and accuracy (60% vs. 90%, p = 0.015) for CT vs. MRI. Conclusions Our results—with reference to the pathological diagnosis—revealed that MRI had a superior diagnostic performance to CT for diagnosing T4b esophageal cancer invading the surrounding organs. An accurate diagnosis of T4b esophageal cancer may facilitate the implementation of appropriate treatment strategies.
- 4 May 2023
- Published by Springer Nature in British Journal of Cancer
- Vol. 129 (1) , 54-60
Chemoradiotherapy versus triplet chemotherapy as initial therapy for T4b esophageal cancer: survival results from a multicenter randomized Phase 2 trial
Background We report the long-term results as primary endpoint in a multicentre randomized prospective Phase 2 trial which compared chemoradiotherapy (CRT) and triplet chemotherapy (CT) as the initial therapy for conversion surgery (CS) in T4b esophageal cancer (EC). Methods Patients with T4b EC were randomly assigned to the CRT group or CT group as initial treatment. CS was performed if resectable after initial or secondary treatment. The primary endpoint was 2-year overall survival, analysed by intention-to-treat. Results The median follow-up period was 43.8 months. The 2-year survival rate was higher in the CRT group (55.1%; 95% CI: 41.1–68.3%) compared to the CT group (34.7%; 95% CI: 22.8–48.9%), although the difference was not significant (P = 0.11). Local and regional lymph node recurrence in patients undergoing R0 resection was significantly higher in the CT group compared to the CRT group (local: 30% versus 8%, respectively, P = 0.03; regional: 37% versus 8%, respectively, P = 0.002). Conclusions Upfront CT was not superior to upfront CRT as induction therapy for T4b EC in terms of 2-year survival and was significantly inferior to upfront CRT in terms of local and regional control. Registration The Japan Registry of Clinical Trials (s051180164).
- 4 May 2023
- Published by Springer Nature in British Journal of Cancer
- Vol. 129 (1) , 54-60
Chemoradiotherapy versus triplet chemotherapy as initial therapy for T4b esophageal cancer: survival results from a multicenter randomized Phase 2 trial
Background We report the long-term results as primary endpoint in a multicentre randomized prospective Phase 2 trial which compared chemoradiotherapy (CRT) and triplet chemotherapy (CT) as the initial therapy for conversion surgery (CS) in T4b esophageal cancer (EC). Methods Patients with T4b EC were randomly assigned to the CRT group or CT group as initial treatment. CS was performed if resectable after initial or secondary treatment. The primary endpoint was 2-year overall survival, analysed by intention-to-treat. Results The median follow-up period was 43.8 months. The 2-year survival rate was higher in the CRT group (55.1%; 95% CI: 41.1–68.3%) compared to the CT group (34.7%; 95% CI: 22.8–48.9%), although the difference was not significant (P = 0.11). Local and regional lymph node recurrence in patients undergoing R0 resection was significantly higher in the CT group compared to the CRT group (local: 30% versus 8%, respectively, P = 0.03; regional: 37% versus 8%, respectively, P = 0.002). Conclusions Upfront CT was not superior to upfront CRT as induction therapy for T4b EC in terms of 2-year survival and was significantly inferior to upfront CRT in terms of local and regional control. Registration The Japan Registry of Clinical Trials (s051180164).
- 1 July 2022
- Published by The Paleontological Society of Japan in Paleontological Research
- Vol. 26 (3) , 301-313
Late Cretaceous Diatoms (Bacillariophyta) from the Teshio-Nakagawa Area, Hokkaido, Northern Japan: Significance for Their Origin and Biostratigraphy
Paleonotological Research publishes work addressing all ages on a global geographic scope with paleontology and related sciences.
- 1 July 2022
- Published by The Paleontological Society of Japan in Paleontological Research
- Vol. 26 (3) , 301-313
Late Cretaceous Diatoms (Bacillariophyta) from the Teshio-Nakagawa Area, Hokkaido, Northern Japan: Significance for Their Origin and Biostratigraphy
Paleonotological Research publishes work addressing all ages on a global geographic scope with paleontology and related sciences.
- Open Access
- 5 June 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (11) , 3219
The Impact of Perioperative Fluid Balance on Postoperative Complications after Esophagectomy for Esophageal Cancer
Background: Perioperative fluid balance is an important indicator in the management of esophageal cancer patients who undergo esophagectomy. However, the association between perioperative fluid balance and postoperative complications after minimally invasive esophagectomy (MIE) remains unclear. Methods: This study included 115 patients with thoracic esophageal squamous cell cancer who underwent MIE between January 2018 and January 2020. We retrospectively evaluated the association between perioperative fluid balance from during surgery to postoperative day (POD) 2, and postoperative complications. Results: The patients were divided into lower group and higher group based on the median fluid balance during surgery and at POD 1 and POD 2. We found that the higher group at POD 1 (≥3000 mL) was the most important indicator of postoperative complications, such as acute pneumonia within 7 days after surgery, and anastomotic leakage (p = 0.029, p = 0.024, respectively). Moreover, the higher group at POD 1 was a significant independent factor for acute postoperative pneumonia by multivariate analysis (OR: 3.270, 95% CI: 1.077–9.929, p = 0.037). Conclusion: This study showed that fluid overload at POD 1 had a negative influence on postoperative complications in patients with esophageal cancer. The fluid balance must be strictly controlled during the early postoperative management of patients undergoing esophageal cancer surgery.
- 5 June 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (11) , 3219
Open AccessThe Impact of Perioperative Fluid Balance on Postoperative Complications after Esophagectomy for Esophageal Cancer
Background: Perioperative fluid balance is an important indicator in the management of esophageal cancer patients who undergo esophagectomy. However, the association between perioperative fluid balance and postoperative complications after minimally invasive esophagectomy (MIE) remains unclear. Methods: This study included 115 patients with thoracic esophageal squamous cell cancer who underwent MIE between January 2018 and January 2020. We retrospectively evaluated the association between perioperative fluid balance from during surgery to postoperative day (POD) 2, and postoperative complications. Results: The patients were divided into lower group and higher group based on the median fluid balance during surgery and at POD 1 and POD 2. We found that the higher group at POD 1 (≥3000 mL) was the most important indicator of postoperative complications, such as acute pneumonia within 7 days after surgery, and anastomotic leakage (p = 0.029, p = 0.024, respectively). Moreover, the higher group at POD 1 was a significant independent factor for acute postoperative pneumonia by multivariate analysis (OR: 3.270, 95% CI: 1.077–9.929, p = 0.037). Conclusion: This study showed that fluid overload at POD 1 had a negative influence on postoperative complications in patients with esophageal cancer. The fluid balance must be strictly controlled during the early postoperative management of patients undergoing esophageal cancer surgery.
- Open Access
- 18 May 2022
- Published by Wolters Kluwer Health in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
- Vol. 32 (3) , 311-318
Robotic Distal Gastrectomy Reduces Drain Amylase Values in Patients With a Small Pancreas-left Gastric Artery Angle
Purpose: Pancreatic fistula is a severe complication after laparoscopic distal gastrectomy (LDG). We previously evaluated the pancreas-left gastric artery angle (PLA) as a risk indicator for developing a pancreatic fistula after LDG. This study evaluated the incidence of pancreatic fistula with robotic distal gastrectomy (RDG) in comparison to LDG from the view of the PLA. Materials and Methods: An association between the PLA and the incidence of pancreatic fistula in 165 patients who underwent either RDG (n=45) or LDG (n=120) was investigated retrospectively. Results: RDG patients had significantly lower drain amylase values (postoperative day 2) than LDG patients. As opposed to LDG patients, drain amylase values were similar for patients with small (PLA <62 degrees) and large (PLA ≥62 degrees) PLA in RDG patients. Conclusion: Robotic surgery may reduce the risk of postoperative pancreatic fistula in patients with a small PLA.
- 18 May 2022
- Published by Wolters Kluwer Health in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
- Vol. 32 (3) , 311-318
Open AccessRobotic Distal Gastrectomy Reduces Drain Amylase Values in Patients With a Small Pancreas-left Gastric Artery Angle
Purpose: Pancreatic fistula is a severe complication after laparoscopic distal gastrectomy (LDG). We previously evaluated the pancreas-left gastric artery angle (PLA) as a risk indicator for developing a pancreatic fistula after LDG. This study evaluated the incidence of pancreatic fistula with robotic distal gastrectomy (RDG) in comparison to LDG from the view of the PLA. Materials and Methods: An association between the PLA and the incidence of pancreatic fistula in 165 patients who underwent either RDG (n=45) or LDG (n=120) was investigated retrospectively. Results: RDG patients had significantly lower drain amylase values (postoperative day 2) than LDG patients. As opposed to LDG patients, drain amylase values were similar for patients with small (PLA <62 degrees) and large (PLA ≥62 degrees) PLA in RDG patients. Conclusion: Robotic surgery may reduce the risk of postoperative pancreatic fistula in patients with a small PLA.